Fig. 4From: GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTsForest plots of meta-analysis of the six CVOTs with GLP-1RA on MACE, in patients with history of CV disease (top) or in patients without such a history (bottom)Back to article page